Przespolewski A - Search Results

1

Updates in novel immunotherapeutic strategies for relapsed/refractory AML.

Bawek S, Gurusinghe S, Burwinkel M, Przespolewski A. Bawek S, et al. Among authors: przespolewski a. Front Oncol. 2024 Dec 4;14:1374963. doi: 10.3389/fonc.2024.1374963. eCollection 2024. Front Oncol. 2024. PMID: 39697225 Free PMC article. Review.

2

Cellular and Molecular Biomarkers Predictive of Response to Immunotherapy in Acute Myeloid Leukemia.

Wiatrowski K, Kim TH, Przespolewski A. Wiatrowski K, et al. Among authors: przespolewski a. Front Oncol. 2022 May 19;12:826768. doi: 10.3389/fonc.2022.826768. eCollection 2022. Front Oncol. 2022. PMID: 35664748 Free PMC article. Review.

3

Advances in immunotherapy for acute myeloid leukemia.

Przespolewski A, Szeles A, Wang ES. Przespolewski A, et al. Future Oncol. 2018 Apr;14(10):963-978. doi: 10.2217/fon-2017-0459. Epub 2018 Mar 15. Future Oncol. 2018. PMID: 29542352 Review.

4

BITES and CARS and checkpoints, oh my! Updates regarding immunotherapy for myeloid malignancies from the 2018 annual ASH meeting.

Przespolewski AC, Griffiths EA. Przespolewski AC, et al. Blood Rev. 2020 Sep;43:100654. doi: 10.1016/j.blre.2020.100654. Epub 2020 Jan 21. Blood Rev. 2020. PMID: 32029263 Free PMC article. Review.

5

Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy.

Talati C, Goldberg AD, Przespolewski A, Chan O, Ali NA, Kim J, Famulare C, Sallman D, Padron E, Kuykendall A, Lancet JE, Wang E, Tallman MS, Komrokji R, Sweet K. Talati C, et al. Among authors: przespolewski a. Leuk Res. 2020 Jun;93:106367. doi: 10.1016/j.leukres.2020.106367. Epub 2020 May 1. Leuk Res. 2020. PMID: 32408060 Free PMC article.

6

Targeting acute myeloid leukemia through multimodal immunotherapeutic approaches.

Przespolewski AC, Portwood S, Wang ES. Przespolewski AC, et al. Leuk Lymphoma. 2022 Apr;63(4):918-927. doi: 10.1080/10428194.2021.1992614. Epub 2021 Nov 25. Leuk Lymphoma. 2022. PMID: 34818963 Free PMC article.

7

Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia.

Przespolewski A, Wang ES. Przespolewski A, et al. Expert Opin Investig Drugs. 2016 Jul;25(7):771-80. doi: 10.1080/13543784.2016.1175432. Epub 2016 Apr 21. Expert Opin Investig Drugs. 2016. PMID: 27077938 Review.

8

Advancing treatment of acute myeloid leukemia: the future of FLT3 inhibitors.

Elshoury A, Przespolewski A, Baron J, Wang ES. Elshoury A, et al. Among authors: przespolewski a. Expert Rev Anticancer Ther. 2019 Mar;19(3):273-286. doi: 10.1080/14737140.2019.1573679. Epub 2019 Feb 6. Expert Rev Anticancer Ther. 2019. PMID: 30681373 Review.

9

PARP goes the weasel! Emerging role of PARP inhibitors in acute leukemias.

Fritz C, Portwood SM, Przespolewski A, Wang ES. Fritz C, et al. Among authors: przespolewski a. Blood Rev. 2021 Jan;45:100696. doi: 10.1016/j.blre.2020.100696. Epub 2020 May 7. Blood Rev. 2021. PMID: 32482307 Free PMC article. Review.

10

Outcomes of Adult Acute Myeloid Leukemia Treated With Gemtuzumab-Ozogamicin: Cue To Optimized Chemotherapy Backbone.

Singh A, Thota S, Bradley T, Griffiths EA, Faber MG, Sadek S, Przespolewski A, Thompson JE, Baron J, Cronin T, Attwood K, Madarang EC, Watts J, Wang ES. Singh A, et al. Among authors: przespolewski a. Clin Lymphoma Myeloma Leuk. 2021 Sep;21(9):613-620. doi: 10.1016/j.clml.2021.04.007. Epub 2021 Apr 12. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34031004 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters